rituximab,ibrutinib,Bendamustine
biogen,roche,novartis,janssen,abbvie
['shine', 'lymphoma', 'mantle,(-dismantle)']
shine: ibrutinib in combination with standard chemo significantly prolonged progression-free survival in patients with untreated mantle-cell lymphoma. #asco22 
The New England Journal of Medicine (https://t.co/YGfDrRsIhE) is the world’s leading medical journal and website.